Susquehanna Fundamental Investments’s Usana Health Sciences USNA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,403	Closed	-$1.33M	–	1771
2021 Q3	$1.33M	Sell	14,403 -3,108	-18%	-$299K	0.02%	752
2021 Q2	$1.79M	Buy	17,511 +775	+5%	+$77.8K	0.03%	636
2021 Q1	$1.63M	Hold	16,736	–	–	0.03%	719
2020 Q4	$1.29M	Buy	16,736 +13,178	+370%	+$1.02M	0.02%	774
2020 Q3	$262K	Buy	+3,558	New	+$285K	0.01%	1109
2018 Q2	–	Sell	-2,400	Closed	-$206K	–	490
2018 Q1	$206K	Buy	+2,400	New	+$186K	0.02%	404

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna Fundamental Investments's USNA Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Usana Health Sciences (USNA) in Q4 2021, closing a stake of 14,403 shares — an estimated $1.33M sold.

Susquehanna Fundamental Investments first reported a position in USNA in Q1 2018 and held it in 6 quarters. The position peaked at $1.79M in Q2 2021. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining Usana Health Sciences position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 14,403 Usana Health Sciences shares in Q4 2021, an estimated $1.33M.
Susquehanna Fundamental Investments first reported a position in Usana Health Sciences in Q1 2018 and held it in 6 quarters.
Susquehanna Fundamental Investments's Usana Health Sciences position peaked at $1.79M in Q2 2021.
191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.